RN 1 dihydrochloride
(Synonyms: LSD1 Inhibitor IV) 目录号 : GC10148An irreversible LSD1 inhibitor
Cas No.:1781835-13-9
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
RN 1 dihydrochloride is a potent and selective inhibitor of LSD1 with IC50 value of 70 nM [1].
Lysine (K) -specific demethylase 1A (LSD1) is a flavin-dependent histone demethylase that demethylates mono- and di-methylated lysines and plays an important role in oocyte growth, embryogenesis and tissue-specific differentiation. LSD1 plays a role in acute myeloid leukemia (AML).
RN 1 dihydrochloride is a potent and selective LSD1 inhibitor. RN-1 inhibited monoamine oxidase MAO A and MAO B with IC50 values of 0.51 and 2.79 μM, respectively [1]. In baboon erythroid progenitor cells, RN-1 increased γ-globin expression [2].
In mice, RN-1 significantly impairs long-term memory but didn’t affect short-term memory [1]. In sickle cell disease (SCD) mice, RN-1 induced the expression of γ-globin and increased amounts of F cells and F reticulocytes [2]. In SCD mouse model, RN-1 induced HbF synthesis and increased amounts of mature erythrocytes and HbF-positive cells. Also, RN-1 reduced sickle cells and reticulocytes in the peripheral blood [3].
References:
[1]. Neelamegam R, Ricq EL, Malvaez M, et al. Brain-penetrant LSD1 inhibitors can block memory consolidation. ACS Chem Neurosci, 2012, 3(2): 120-128.
[2]. Rivers A, Vaitkus K, Ruiz MA, et al. RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model. Exp Hematol, 2015, 43(7): 546-553.e3.
[3]. Cui S, Lim KC, Shi L, et al. The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice. Blood, 2015, pii: blood-2015-02-626259.
Cas No. | 1781835-13-9 | SDF | |
别名 | LSD1 Inhibitor IV | ||
化学名 | 2-(((1R,2S)-2-(4-(benzyloxy)phenyl)cyclopropyl)amino)-1-(4-methylpiperazin-1-yl)ethanone dihydrochloride | ||
Canonical SMILES | CN1CCN(C(CN[C@]2([H])C[C@@]2([H])C3=CC=C(OCC4=CC=CC=C4)C=C3)=O)CC1.Cl.Cl | ||
分子式 | C23H29N3O2.2HCl | 分子量 | 452.42 |
溶解度 | <9.05mg/ml in Water; <9.05mg/ml in DMSO | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.2103 mL | 11.0517 mL | 22.1034 mL |
5 mM | 0.4421 mL | 2.2103 mL | 4.4207 mL |
10 mM | 0.221 mL | 1.1052 mL | 2.2103 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。